Natalie Wildenradt

Natalie Wildenradt currently serves as the Senior Director of Investor Relations, Public Relations, and Corporate Development at HotSpot Therapeutics, Inc., a position held since December 2021. Prior to this role, Natalie held various positions at Black Diamond Therapeutics, including Director of Investor Relations and Corporate Communications, and earlier served as Associate Director in the same field. Experience also includes roles at Ra Pharmaceuticals and Argot Partners, where Natalie progressed from Junior Associate to Assistant Vice President. Natalie holds a Bachelor of Arts degree in Economics and Biology from Wesleyan University, earned between 2011 and 2015.